| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0022 | 0.9 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | -0.002 | 0.9 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.002 | 0.9 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.002 | 1 |